We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final Guidance Focuses on Radiolabeled Mass Balance Studies of Investigational Drugs
Final Guidance Focuses on Radiolabeled Mass Balance Studies of Investigational Drugs
The FDA has issued a final guidance with recommendations on clinical pharmacology considerations for conducting human radiolabeled mass balance studies, including deciding whether and when to conduct the study, designing the study, and reporting results.